10-QPeriod: Q1 FY2008

Elevance Health, Inc. Quarterly Report for Q1 Ended Mar 31, 2008

Filed April 23, 2008For Securities:ELV

Summary

Elevance Health, Inc. (formerly WellPoint, Inc.) reported its first quarter 2008 financial results, showing a slight increase in operating revenue to $15.4 billion, up 4% year-over-year, primarily driven by growth in its Medicare Advantage business and premium rate adjustments. However, net income declined by 25% to $588.1 million, or $1.07 per diluted share, compared to the prior year. This decrease is attributed to higher-than-anticipated medical costs, less favorable prior year reserve development, and lower fully-insured enrollment. The company experienced a significant increase in benefit expenses, up 6% year-over-year, contributing to a higher benefit expense ratio. While investment income saw a modest decrease, the company recorded substantial net realized investment losses, largely due to other-than-temporary impairments on equity and fixed maturity securities amid challenging market conditions. Despite the decline in profitability, the company maintained a strong liquidity position with $20.2 billion in cash, cash equivalents, and investments. Management remains focused on managing medical costs and operational efficiencies.

Key Highlights

  • 1Operating revenue increased 4% to $15.4 billion, driven by Medicare Advantage growth and premium rate increases.
  • 2Net income decreased 25% to $588.1 million, with diluted EPS falling to $1.07 from $1.26 year-over-year.
  • 3Benefit expenses rose 6% due to higher medical costs and less favorable prior year reserve development.
  • 4The company incurred significant net realized investment losses of $45.6 million, primarily from impairments.
  • 5Total medical membership grew slightly by 1% to 35.4 million, with an increase in self-funded membership offsetting a decline in fully-insured enrollment.
  • 6The company repurchased approximately $2.0 billion of its common stock during the quarter.
  • 7Operating cash flow decreased to $1.0 billion from $2.0 billion in the prior year, impacted by CMS payment timing and lower net income.

Frequently Asked Questions

The primary drivers for the decrease in net income were higher-than-expected medical costs, less favorable prior year reserve development, and lower fully-insured enrollment. These factors led to a significant increase in benefit expenses, which negatively impacted profitability.

Investment performance was weak, with the company reporting net realized investment losses of $45.6 million. This was primarily due to other-than-temporary impairments on equity and fixed maturity securities, reflecting the challenging market conditions during the quarter.

Management noted higher than anticipated medical costs impacting the current quarter and indicated that these factors might continue for the remainder of the year. The company is focused on implementing medical cost management initiatives and operational efficiencies to mitigate these pressures.

Yes, the company continued its share repurchase program, buying back approximately $2.0 billion of its common stock during the quarter. This is viewed as a prudent use of surplus capital.